[Drug therapy of aphasic disorders following brain injury and cerebral vascular involvement].
D000085:Acetates / Q000627:therapeutic use*; D001037:Aphasia / Q000188:drug therapy* / Q000209:etiology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000209:etiology; D006259:Craniocerebral Trauma / Q000150:complications*; D006801:Humans; D002504:Meclofenoxate / Q000627:therapeutic use; D011379:Prognosis
D000085:Acetates; D000697:Central Nervous System Stimulants; D002504:Meclofenoxate
Beitrag zur medikamentösen Therapie aphasischer Störungen nach Hirntraumen und zerbralen Gefässprozessen.